,title,geo_accession,status,submission_date,last_update_date,type,channel_count,source_name_ch1,organism_ch1,characteristics_ch1,characteristics_ch1.1,characteristics_ch1.2,characteristics_ch1.3,characteristics_ch1.4,characteristics_ch1.5,characteristics_ch1.6,treatment_protocol_ch1,growth_protocol_ch1,molecule_ch1,extract_protocol_ch1,label_ch1,label_protocol_ch1,taxid_ch1,hyb_protocol,scan_protocol,description,data_processing,platform_id,contact_name,contact_email,contact_phone,contact_fax,contact_department,contact_institute,contact_address,contact_city,contact_zip/postal_code,contact_country,supplementary_file,data_row_count
GSM516678,Ovarian carcinoma_OC01_ARN0001 [HG-U133_Plus_2],GSM516678,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0001,histotype: Serous,tumor/metastasis: T,grade: 3,stade: Ib,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516678/GSM516678.CEL.gz,54675
GSM516679,Ovarian carcinoma_OC01_ARN0002 [HG-U133_Plus_2],GSM516679,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0002,histotype: Endometrioid,tumor/metastasis: T,grade: 2,stade: IIb,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516679/GSM516679.CEL.gz,54675
GSM516680,Ovarian carcinoma_OC01_ARN0004 [HG-U133_Plus_2],GSM516680,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0004,histotype: Serous,tumor/metastasis: T,grade: 3,stade: IIIc,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516680/GSM516680.CEL.gz,54675
GSM516681,Ovarian carcinoma_OC01_ARN0005 [HG-U133_Plus_2],GSM516681,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0005,histotype: Serous,tumor/metastasis: T,grade: 3,stade: IV,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516681/GSM516681.CEL.gz,54675
GSM516682,Plausible Breast metastasis in the ovary_OC01_ARN0006 [HG-U133_Plus_2],GSM516682,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Plausible Breast metastasis in the ovary,Homo sapiens,tissue: Ovary,histology (disease state): Plausible Breast metastasis in the ovary,identifier: OC01_ARN0006,histotype: N/A,tumor/metastasis: M,grade: N/A,stade: N/A,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from breast metastasis in the ovary,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516682/GSM516682.CEL.gz,54675
GSM516683,Ovarian carcinoma_OC01_ARN0007 [HG-U133_Plus_2],GSM516683,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0007,histotype: Serous,tumor/metastasis: T,grade: 3,stade: IIIc,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516683/GSM516683.CEL.gz,54675
GSM516684,Ovarian carcinoma_OC01_ARN0008 [HG-U133_Plus_2],GSM516684,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0008,histotype: Serous,tumor/metastasis: T,grade: 3,stade: IIIc,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516684/GSM516684.CEL.gz,54675
GSM516685,Ovarian carcinoma_OC01_ARN0009 [HG-U133_Plus_2],GSM516685,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0009,histotype: Serous,tumor/metastasis: T,grade: 2,stade: IIIc,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516685/GSM516685.CEL.gz,54675
GSM516686,Ovarian carcinoma_OC01_ARN0010 [HG-U133_Plus_2],GSM516686,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0010,histotype: Serous,tumor/metastasis: T,grade: 3,stade: N/A,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516686/GSM516686.CEL.gz,54675
GSM516687,Ovarian carcinoma_OC01_ARN0011 [HG-U133_Plus_2],GSM516687,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0011,histotype: Serous,tumor/metastasis: T,grade: 2,stade: Ib,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516687/GSM516687.CEL.gz,54675
GSM516688,Ovarian carcinoma_OC01_ARN0012 [HG-U133_Plus_2],GSM516688,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0012,histotype: Serous,tumor/metastasis: T,grade: 1,stade: Ib,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516688/GSM516688.CEL.gz,54675
GSM516689,Ovarian carcinoma_OC01_ARN0013 [HG-U133_Plus_2],GSM516689,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0013,histotype: Mucinous,tumor/metastasis: T,grade: 3,stade: IIIc,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516689/GSM516689.CEL.gz,54675
GSM516690,Plausible Ovarian carcinoma_OC01_ARN0014 [HG-U133_Plus_2],GSM516690,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Plausible Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Plausible Ovarian carcinoma,identifier: OC01_ARN0014,histotype: Serous,tumor/metastasis: T,grade: 3,stade: IIIc,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516690/GSM516690.CEL.gz,54675
GSM516691,Ovarian carcinoma_OC01_ARN0015 [HG-U133_Plus_2],GSM516691,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0015,histotype: Serous,tumor/metastasis: T,grade: 3,stade: IV,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516691/GSM516691.CEL.gz,54675
GSM516692,Breast metastasis in the ovary_OC01_ARN0016 [HG-U133_Plus_2],GSM516692,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Breast metastasis in the ovary,Homo sapiens,tissue: Ovary,histology (disease state): Breast metastasis in the ovary,identifier: OC01_ARN0016,histotype: N/A,tumor/metastasis: M,grade: N/A,stade: N/A,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from breast metastasis in the ovary,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516692/GSM516692.CEL.gz,54675
GSM516693,Breast metastasis in the ovary_OC01_ARN0017 [HG-U133_Plus_2],GSM516693,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Breast metastasis in the ovary,Homo sapiens,tissue: Ovary,histology (disease state): Breast metastasis in the ovary,identifier: OC01_ARN0017,histotype: N/A,tumor/metastasis: M,grade: N/A,stade: N/A,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from breast metastasis in the ovary,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516693/GSM516693.CEL.gz,54675
GSM516694,Plausible Ovarian carcinoma_OC01_ARN0019 [HG-U133_Plus_2],GSM516694,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Plausible Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Plausible Ovarian carcinoma,identifier: OC01_ARN0019,histotype: Serous,tumor/metastasis: T,grade: 3,stade: IIb,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516694/GSM516694.CEL.gz,54675
GSM516695,Breast metastasis in the ovary_OC01_ARN0020 [HG-U133_Plus_2],GSM516695,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Breast metastasis in the ovary,Homo sapiens,tissue: Ovary,histology (disease state): Breast metastasis in the ovary,identifier: OC01_ARN0020,histotype: N/A,tumor/metastasis: M,grade: N/A,stade: N/A,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from breast metastasis in the ovary,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516695/GSM516695.CEL.gz,54675
GSM516696,Plausible Breast metastasis in the ovary_OC01_ARN0021 [HG-U133_Plus_2],GSM516696,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Plausible Breast metastasis in the ovary,Homo sapiens,tissue: Ovary,histology (disease state): Plausible Breast metastasis in the ovary,identifier: OC01_ARN0021,histotype: N/A,tumor/metastasis: M,grade: N/A,stade: N/A,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from breast metastasis in the ovary,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516696/GSM516696.CEL.gz,54675
GSM516697,Ovarian carcinoma_OC01_ARN0022 [HG-U133_Plus_2],GSM516697,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0022,histotype: Serous,tumor/metastasis: T,grade: 2,stade: Ia,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516697/GSM516697.CEL.gz,54675
GSM516698,Ovarian carcinoma_OC01_ARN0023 [HG-U133_Plus_2],GSM516698,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0023,histotype: Serous,tumor/metastasis: T,grade: 3,stade: IV,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516698/GSM516698.CEL.gz,54675
GSM516699,Ovarian carcinoma_OC01_ARN0025 [HG-U133_Plus_2],GSM516699,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0025,histotype: Serous,tumor/metastasis: T,grade: 3,stade: IV,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516699/GSM516699.CEL.gz,54675
GSM516700,Ovarian carcinoma_OC01_ARN0028 [HG-U133_Plus_2],GSM516700,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0028,histotype: Serous,tumor/metastasis: T,grade: 1,stade: IV,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516700/GSM516700.CEL.gz,54675
GSM516701,Breast metastasis in the ovary_OC01_ARN0029 [HG-U133_Plus_2],GSM516701,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Breast metastasis in the ovary,Homo sapiens,tissue: Ovary,histology (disease state): Breast metastasis in the ovary,identifier: OC01_ARN0029,histotype: N/A,tumor/metastasis: M,grade: N/A,stade: N/A,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from breast metastasis in the ovary,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516701/GSM516701.CEL.gz,54675
GSM516702,Ovarian carcinoma_OC01_ARN0030 [HG-U133_Plus_2],GSM516702,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0030,histotype: Endometrioid,tumor/metastasis: T,grade: 3,stade: IIIc,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516702/GSM516702.CEL.gz,54675
GSM516703,Ovarian carcinoma_OC01_ARN0032 [HG-U133_Plus_2],GSM516703,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0032,histotype: Mucinous,tumor/metastasis: T,grade: 2,stade: Ia,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516703/GSM516703.CEL.gz,54675
GSM516704,Ovarian carcinoma_OC01_ARN0034 [HG-U133_Plus_2],GSM516704,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0034,histotype: Serous,tumor/metastasis: T,grade: 3,stade: IIIc,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516704/GSM516704.CEL.gz,54675
GSM516705,Breast metastasis in the ovary_OC01_ARN0035 [HG-U133_Plus_2],GSM516705,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Breast metastasis in the ovary,Homo sapiens,tissue: Ovary,histology (disease state): Breast metastasis in the ovary,identifier: OC01_ARN0035,histotype: N/A,tumor/metastasis: M,grade: N/A,stade: N/A,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from breast metastasis in the ovary,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516705/GSM516705.CEL.gz,54675
GSM516706,Ovarian carcinoma_OC01_ARN0036 [HG-U133_Plus_2],GSM516706,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0036,histotype: Serous,tumor/metastasis: T,grade: 2,stade: Ic,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516706/GSM516706.CEL.gz,54675
GSM516707,Ovarian carcinoma_OC01_ARN0037 [HG-U133_Plus_2],GSM516707,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0037,histotype: Serous,tumor/metastasis: T,grade: 2,stade: IIIc,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516707/GSM516707.CEL.gz,54675
GSM516708,Ovarian carcinoma_OC01_ARN0038 [HG-U133_Plus_2],GSM516708,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0038,histotype: Serous,tumor/metastasis: T,grade: 3,stade: IIIc,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516708/GSM516708.CEL.gz,54675
GSM516709,Ovarian carcinoma_OC01_ARN0039 [HG-U133_Plus_2],GSM516709,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0039,histotype: Serous,tumor/metastasis: T,grade: 3,stade: IIIc,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516709/GSM516709.CEL.gz,54675
GSM516710,Plausible Ovarian carcinoma_OC01_ARN0040 [HG-U133_Plus_2],GSM516710,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Plausible Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Plausible Ovarian carcinoma,identifier: OC01_ARN0040,histotype: Serous,tumor/metastasis: T,grade: 3,stade: IIIc,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516710/GSM516710.CEL.gz,54675
GSM516711,Ovarian carcinoma_OC01_ARN0041 [HG-U133_Plus_2],GSM516711,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0041,histotype: Clear Cells,tumor/metastasis: T,grade: 2,stade: IIIb,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516711/GSM516711.CEL.gz,54675
GSM516712,Ovarian carcinoma_OC01_ARN0042 [HG-U133_Plus_2],GSM516712,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0042,histotype: Mucinous,tumor/metastasis: T,grade: 1,stade: Ia,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516712/GSM516712.CEL.gz,54675
GSM516713,Ovarian carcinoma_OC01_ARN0045 [HG-U133_Plus_2],GSM516713,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0045,histotype: Adenocarcinoma,tumor/metastasis: T,grade: 3,stade: IV,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516713/GSM516713.CEL.gz,54675
GSM516714,Breast metastasis in the ovary_OC01_ARN0046 [HG-U133_Plus_2],GSM516714,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Breast metastasis in the ovary,Homo sapiens,tissue: Ovary,histology (disease state): Breast metastasis in the ovary,identifier: OC01_ARN0046,histotype: N/A,tumor/metastasis: M,grade: N/A,stade: N/A,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from breast metastasis in the ovary,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516714/GSM516714.CEL.gz,54675
GSM516715,Ovarian carcinoma_OC01_ARN0049 [HG-U133_Plus_2],GSM516715,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0049,histotype: Serous,tumor/metastasis: T,grade: 3,stade: IIIc,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516715/GSM516715.CEL.gz,54675
GSM516716,Breast metastasis in the ovary_OC01_ARN0051 [HG-U133_Plus_2],GSM516716,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Breast metastasis in the ovary,Homo sapiens,tissue: Ovary,histology (disease state): Breast metastasis in the ovary,identifier: OC01_ARN0051,histotype: N/A,tumor/metastasis: M,grade: N/A,stade: N/A,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from breast metastasis in the ovary,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516716/GSM516716.CEL.gz,54675
GSM516717,Breast metastasis in the ovary_OC01_ARN0053 [HG-U133_Plus_2],GSM516717,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Breast metastasis in the ovary,Homo sapiens,tissue: Ovary,histology (disease state): Breast metastasis in the ovary,identifier: OC01_ARN0053,histotype: N/A,tumor/metastasis: M,grade: N/A,stade: N/A,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from breast metastasis in the ovary,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516717/GSM516717.CEL.gz,54675
GSM516718,Breast metastasis in the ovary_OC01_ARN0055 [HG-U133_Plus_2],GSM516718,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Breast metastasis in the ovary,Homo sapiens,tissue: Ovary,histology (disease state): Breast metastasis in the ovary,identifier: OC01_ARN0055,histotype: N/A,tumor/metastasis: M,grade: N/A,stade: N/A,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from breast metastasis in the ovary,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516718/GSM516718.CEL.gz,54675
GSM516719,Plausible Breast metastasis in the ovary_OC01_ARN0056 [HG-U133_Plus_2],GSM516719,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Plausible Breast metastasis in the ovary,Homo sapiens,tissue: Ovary,histology (disease state): Plausible Breast metastasis in the ovary,identifier: OC01_ARN0056,histotype: N/A,tumor/metastasis: M,grade: N/A,stade: N/A,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from breast metastasis in the ovary,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516719/GSM516719.CEL.gz,54675
GSM516720,Ovarian carcinoma_OC01_ARN0057 [HG-U133_Plus_2],GSM516720,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0057,histotype: Mucinous,tumor/metastasis: T,grade: 2,stade: Ic,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516720/GSM516720.CEL.gz,54675
GSM516721,Ovarian carcinoma_OC01_ARN0058 [HG-U133_Plus_2],GSM516721,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0058,histotype: Clear Cells,tumor/metastasis: T,grade: 3,stade: Ic,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516721/GSM516721.CEL.gz,54675
GSM516722,Breast metastasis in the ovary_OC01_ARN0060 [HG-U133_Plus_2],GSM516722,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Breast metastasis in the ovary,Homo sapiens,tissue: Ovary,histology (disease state): Breast metastasis in the ovary,identifier: OC01_ARN0060,histotype: N/A,tumor/metastasis: M,grade: N/A,stade: N/A,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from breast metastasis in the ovary,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516722/GSM516722.CEL.gz,54675
GSM516723,Ovarian carcinoma_OC01_ARN0061 [HG-U133_Plus_2],GSM516723,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0061,histotype: Serous,tumor/metastasis: T,grade: 3,stade: IIIc,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516723/GSM516723.CEL.gz,54675
GSM516724,Ovarian carcinoma_OC01_ARN0062 [HG-U133_Plus_2],GSM516724,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0062,histotype: Serous,tumor/metastasis: T,grade: 3,stade: IIIc,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516724/GSM516724.CEL.gz,54675
GSM516725,Ovarian carcinoma_OC01_ARN0063 [HG-U133_Plus_2],GSM516725,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0063,histotype: Serous,tumor/metastasis: T,grade: 2,stade: IIIc,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516725/GSM516725.CEL.gz,54675
GSM516726,Ovarian carcinoma_OC01_ARN0064 [HG-U133_Plus_2],GSM516726,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0064,histotype: Serous,tumor/metastasis: T,grade: 3,stade: IV,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516726/GSM516726.CEL.gz,54675
GSM516727,Ovarian carcinoma_OC01_ARN0066 [HG-U133_Plus_2],GSM516727,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0066,histotype: Serous,tumor/metastasis: T,grade: 3,stade: IIIc,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516727/GSM516727.CEL.gz,54675
GSM516728,Ovarian carcinoma_OC01_ARN0067 [HG-U133_Plus_2],GSM516728,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0067,histotype: Mucinous,tumor/metastasis: T,grade: 2,stade: Ic,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516728/GSM516728.CEL.gz,54675
GSM516729,Breast metastasis in the ovary_OC01_ARN0069 [HG-U133_Plus_2],GSM516729,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Breast metastasis in the ovary,Homo sapiens,tissue: Ovary,histology (disease state): Breast metastasis in the ovary,identifier: OC01_ARN0069,histotype: N/A,tumor/metastasis: M,grade: N/A,stade: N/A,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from breast metastasis in the ovary,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516729/GSM516729.CEL.gz,54675
GSM516730,Ovarian carcinoma_OC01_ARN0070 [HG-U133_Plus_2],GSM516730,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0070,histotype: Serous,tumor/metastasis: T,grade: 3,stade: IIIc,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516730/GSM516730.CEL.gz,54675
GSM516731,Ovarian carcinoma_OC01_ARN0072 [HG-U133_Plus_2],GSM516731,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0072,histotype: Serous,tumor/metastasis: T,grade: 2,stade: IIb,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516731/GSM516731.CEL.gz,54675
GSM516732,Breast metastasis in the ovary_OC01_ARN0073 [HG-U133_Plus_2],GSM516732,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Breast metastasis in the ovary,Homo sapiens,tissue: Ovary,histology (disease state): Breast metastasis in the ovary,identifier: OC01_ARN0073,histotype: N/A,tumor/metastasis: M,grade: N/A,stade: N/A,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from breast metastasis in the ovary,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516732/GSM516732.CEL.gz,54675
GSM516733,Plausible Ovarian carcinoma_OC01_ARN0074 [HG-U133_Plus_2],GSM516733,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Plausible Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Plausible Ovarian carcinoma,identifier: OC01_ARN0074,histotype: Serous,tumor/metastasis: T,grade: 3,stade: Ib,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516733/GSM516733.CEL.gz,54675
GSM516734,Ovarian carcinoma_OC01_ARN0075 [HG-U133_Plus_2],GSM516734,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0075,histotype: Serous,tumor/metastasis: T,grade: 2,stade: IIIc,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516734/GSM516734.CEL.gz,54675
GSM516735,Ovarian carcinoma_OC01_ARN0076 [HG-U133_Plus_2],GSM516735,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0076,histotype: Brenner Tumor,tumor/metastasis: T,grade: 3,stade: IIIc,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516735/GSM516735.CEL.gz,54675
GSM516736,Breast metastasis in the ovary_OC01_ARN0077 [HG-U133_Plus_2],GSM516736,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Breast metastasis in the ovary,Homo sapiens,tissue: Ovary,histology (disease state): Breast metastasis in the ovary,identifier: OC01_ARN0077,histotype: N/A,tumor/metastasis: M,grade: N/A,stade: N/A,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from breast metastasis in the ovary,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516736/GSM516736.CEL.gz,54675
GSM516737,Plausible Ovarian carcinoma_OC01_ARN0078 [HG-U133_Plus_2],GSM516737,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Plausible Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Plausible Ovarian carcinoma,identifier: OC01_ARN0078,histotype: Serous,tumor/metastasis: T,grade: 3,stade: N/A,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516737/GSM516737.CEL.gz,54675
GSM516738,Breast metastasis in the ovary_OC01_ARN0079 [HG-U133_Plus_2],GSM516738,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Breast metastasis in the ovary,Homo sapiens,tissue: Ovary,histology (disease state): Breast metastasis in the ovary,identifier: OC01_ARN0079,histotype: N/A,tumor/metastasis: M,grade: N/A,stade: N/A,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from breast metastasis in the ovary,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516738/GSM516738.CEL.gz,54675
GSM516739,Ovarian carcinoma_OC01_ARN0080 [HG-U133_Plus_2],GSM516739,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0080,histotype: Serous,tumor/metastasis: T,grade: 2,stade: IIIc,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516739/GSM516739.CEL.gz,54675
GSM516740,Breast metastasis in the ovary_OC01_ARN0081 [HG-U133_Plus_2],GSM516740,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Breast metastasis in the ovary,Homo sapiens,tissue: Ovary,histology (disease state): Breast metastasis in the ovary,identifier: OC01_ARN0081,histotype: N/A,tumor/metastasis: M,grade: N/A,stade: N/A,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from breast metastasis in the ovary,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516740/GSM516740.CEL.gz,54675
GSM516741,Breast metastasis in the ovary_OC01_ARN0083 [HG-U133_Plus_2],GSM516741,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Breast metastasis in the ovary,Homo sapiens,tissue: Ovary,histology (disease state): Breast metastasis in the ovary,identifier: OC01_ARN0083,histotype: N/A,tumor/metastasis: M,grade: N/A,stade: N/A,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from breast metastasis in the ovary,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516741/GSM516741.CEL.gz,54675
GSM516742,Ovarian carcinoma_OC01_ARN0084 [HG-U133_Plus_2],GSM516742,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0084,histotype: Serous,tumor/metastasis: T,grade: 2,stade: IIIc,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516742/GSM516742.CEL.gz,54675
GSM516743,Ovarian carcinoma_OC01_ARN0085 [HG-U133_Plus_2],GSM516743,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0085,histotype: Clear Cells,tumor/metastasis: T,grade: 2,stade: Ia,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516743/GSM516743.CEL.gz,54675
GSM516744,Plausible Breast metastasis in the ovary_OC01_ARN0088 [HG-U133_Plus_2],GSM516744,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Plausible Breast metastasis in the ovary,Homo sapiens,tissue: Ovary,histology (disease state): Plausible Breast metastasis in the ovary,identifier: OC01_ARN0088,histotype: N/A,tumor/metastasis: M,grade: N/A,stade: N/A,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from breast metastasis in the ovary,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516744/GSM516744.CEL.gz,54675
GSM516745,Ovarian carcinoma_OC01_ARN0089 [HG-U133_Plus_2],GSM516745,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0089,histotype: Serous,tumor/metastasis: T,grade: 3,stade: IIIc,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516745/GSM516745.CEL.gz,54675
GSM516746,Plausible Breast metastasis in the ovary_OC01_ARN0090 [HG-U133_Plus_2],GSM516746,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Plausible Breast metastasis in the ovary,Homo sapiens,tissue: Ovary,histology (disease state): Plausible Breast metastasis in the ovary,identifier: OC01_ARN0090,histotype: N/A,tumor/metastasis: M,grade: N/A,stade: N/A,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from breast metastasis in the ovary,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516746/GSM516746.CEL.gz,54675
GSM516747,Ovarian carcinoma_OC01_ARN0091 [HG-U133_Plus_2],GSM516747,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0091,histotype: Adenocarcinoma,tumor/metastasis: T,grade: 3,stade: IIa,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516747/GSM516747.CEL.gz,54675
GSM516748,Breast metastasis in the ovary_OC01_ARN0092 [HG-U133_Plus_2],GSM516748,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Breast metastasis in the ovary,Homo sapiens,tissue: Ovary,histology (disease state): Breast metastasis in the ovary,identifier: OC01_ARN0092,histotype: N/A,tumor/metastasis: M,grade: N/A,stade: N/A,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from breast metastasis in the ovary,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516748/GSM516748.CEL.gz,54675
GSM516749,Ovarian carcinoma_OC01_ARN0093 [HG-U133_Plus_2],GSM516749,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0093,histotype: Serous,tumor/metastasis: T,grade: 3,stade: IIIc,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516749/GSM516749.CEL.gz,54675
GSM516750,Ovarian carcinoma_OC01_ARN0095 [HG-U133_Plus_2],GSM516750,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0095,histotype: Serous,tumor/metastasis: T,grade: 2,stade: IIIb,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516750/GSM516750.CEL.gz,54675
GSM516751,Ovarian carcinoma_OC01_ARN0096 [HG-U133_Plus_2],GSM516751,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0096,histotype: Mucinous,tumor/metastasis: T,grade: 1,stade: IIIc,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516751/GSM516751.CEL.gz,54675
GSM516752,Breast metastasis in the ovary_OC01_ARN0097 [HG-U133_Plus_2],GSM516752,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Breast metastasis in the ovary,Homo sapiens,tissue: Ovary,histology (disease state): Breast metastasis in the ovary,identifier: OC01_ARN0097,histotype: N/A,tumor/metastasis: M,grade: N/A,stade: N/A,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from breast metastasis in the ovary,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516752/GSM516752.CEL.gz,54675
GSM516753,Breast metastasis in the ovary_OC01_ARN0098 [HG-U133_Plus_2],GSM516753,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Breast metastasis in the ovary,Homo sapiens,tissue: Ovary,histology (disease state): Breast metastasis in the ovary,identifier: OC01_ARN0098,histotype: N/A,tumor/metastasis: M,grade: N/A,stade: N/A,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from breast metastasis in the ovary,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516753/GSM516753.CEL.gz,54675
GSM516754,Breast metastasis in the ovary_OC01_ARN0099 [HG-U133_Plus_2],GSM516754,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Breast metastasis in the ovary,Homo sapiens,tissue: Ovary,histology (disease state): Breast metastasis in the ovary,identifier: OC01_ARN0099,histotype: N/A,tumor/metastasis: M,grade: N/A,stade: N/A,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from breast metastasis in the ovary,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516754/GSM516754.CEL.gz,54675
GSM516755,Ovarian carcinoma_OC01_ARN0100 [HG-U133_Plus_2],GSM516755,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0100,histotype: Serous,tumor/metastasis: T,grade: 3,stade: IIb,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516755/GSM516755.CEL.gz,54675
GSM516756,Ovarian carcinoma_OC01_ARN0101 [HG-U133_Plus_2],GSM516756,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0101,histotype: Clear Cells,tumor/metastasis: T,grade: 3,stade: IV,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516756/GSM516756.CEL.gz,54675
GSM516757,Breast metastasis in the ovary_OC01_ARN0102 [HG-U133_Plus_2],GSM516757,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Breast metastasis in the ovary,Homo sapiens,tissue: Ovary,histology (disease state): Breast metastasis in the ovary,identifier: OC01_ARN0102,histotype: N/A,tumor/metastasis: M,grade: N/A,stade: N/A,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from breast metastasis in the ovary,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516757/GSM516757.CEL.gz,54675
GSM516758,Ovarian carcinoma_OC01_ARN0103 [HG-U133_Plus_2],GSM516758,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0103,histotype: Serous,tumor/metastasis: T,grade: 3,stade: IIIc,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516758/GSM516758.CEL.gz,54675
GSM516759,Breast metastasis in the ovary_OC01_ARN0104 [HG-U133_Plus_2],GSM516759,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Breast metastasis in the ovary,Homo sapiens,tissue: Ovary,histology (disease state): Breast metastasis in the ovary,identifier: OC01_ARN0104,histotype: N/A,tumor/metastasis: M,grade: N/A,stade: N/A,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from breast metastasis in the ovary,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516759/GSM516759.CEL.gz,54675
GSM516760,Ovarian carcinoma_OC01_ARN0105 [HG-U133_Plus_2],GSM516760,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0105,histotype: Serous,tumor/metastasis: T,grade: 3,stade: IIIc,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516760/GSM516760.CEL.gz,54675
GSM516761,Ovarian carcinoma_OC01_ARN0106 [HG-U133_Plus_2],GSM516761,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0106,histotype: Serous,tumor/metastasis: T,grade: 3,stade: IIIc,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516761/GSM516761.CEL.gz,54675
GSM516762,Ovarian carcinoma_OC01_ARN0107 [HG-U133_Plus_2],GSM516762,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0107,histotype: Serous,tumor/metastasis: T,grade: 2,stade: IIIc,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516762/GSM516762.CEL.gz,54675
GSM516763,Ovarian carcinoma_OC01_ARN0108 [HG-U133_Plus_2],GSM516763,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0108,histotype: Serous,tumor/metastasis: T,grade: 3,stade: IIIc,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516763/GSM516763.CEL.gz,54675
GSM516764,Ovarian carcinoma_OC01_ARN0109 [HG-U133_Plus_2],GSM516764,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0109,histotype: Clear Cells,tumor/metastasis: T,grade: 2,stade: IIa,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516764/GSM516764.CEL.gz,54675
GSM516765,Ovarian carcinoma_OC01_ARN0111 [HG-U133_Plus_2],GSM516765,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0111,histotype: Serous,tumor/metastasis: T,grade: 3,stade: IIIc,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516765/GSM516765.CEL.gz,54675
GSM516766,Breast metastasis in the ovary_OC01_ARN0112 [HG-U133_Plus_2],GSM516766,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Breast metastasis in the ovary,Homo sapiens,tissue: Ovary,histology (disease state): Breast metastasis in the ovary,identifier: OC01_ARN0112,histotype: N/A,tumor/metastasis: M,grade: N/A,stade: N/A,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from breast metastasis in the ovary,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516766/GSM516766.CEL.gz,54675
GSM516767,Ovarian carcinoma_OC01_ARN0113 [HG-U133_Plus_2],GSM516767,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0113,histotype: Endometrioid,tumor/metastasis: T,grade: 1,stade: IIa,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516767/GSM516767.CEL.gz,54675
GSM516768,Ovarian carcinoma_OC01_ARN0114 [HG-U133_Plus_2],GSM516768,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0114,histotype: Carcinosarcoma,tumor/metastasis: T,grade: 3,stade: IIIc,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516768/GSM516768.CEL.gz,54675
GSM516769,Ovarian carcinoma_OC01_ARN0115 [HG-U133_Plus_2],GSM516769,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0115,histotype: Endometrioid,tumor/metastasis: T,grade: 2,stade: Ia,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516769/GSM516769.CEL.gz,54675
GSM516770,Ovarian carcinoma_OC01_ARN0116 [HG-U133_Plus_2],GSM516770,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0116,histotype: Serous,tumor/metastasis: T,grade: 2,stade: IV,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516770/GSM516770.CEL.gz,54675
GSM516771,Ovarian carcinoma_OC01_ARN0118 [HG-U133_Plus_2],GSM516771,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0118,histotype: Serous,tumor/metastasis: T,grade: 2,stade: IIIa,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516771/GSM516771.CEL.gz,54675
GSM516772,Ovarian carcinoma_OC01_ARN0119 [HG-U133_Plus_2],GSM516772,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0119,histotype: Serous,tumor/metastasis: T,grade: 3,stade: IIIc,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516772/GSM516772.CEL.gz,54675
GSM516773,Breast metastasis in the ovary_OC01_ARN0120 [HG-U133_Plus_2],GSM516773,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Breast metastasis in the ovary,Homo sapiens,tissue: Ovary,histology (disease state): Breast metastasis in the ovary,identifier: OC01_ARN0120,histotype: N/A,tumor/metastasis: M,grade: N/A,stade: N/A,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from breast metastasis in the ovary,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516773/GSM516773.CEL.gz,54675
GSM516774,Breast metastasis in the ovary_OC01_ARN0121 [HG-U133_Plus_2],GSM516774,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Breast metastasis in the ovary,Homo sapiens,tissue: Ovary,histology (disease state): Breast metastasis in the ovary,identifier: OC01_ARN0121,histotype: N/A,tumor/metastasis: M,grade: N/A,stade: N/A,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from breast metastasis in the ovary,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516774/GSM516774.CEL.gz,54675
GSM516775,Breast metastasis in the ovary_OC01_ARN0123 [HG-U133_Plus_2],GSM516775,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Breast metastasis in the ovary,Homo sapiens,tissue: Ovary,histology (disease state): Breast metastasis in the ovary,identifier: OC01_ARN0123,histotype: N/A,tumor/metastasis: M,grade: N/A,stade: N/A,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from breast metastasis in the ovary,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516775/GSM516775.CEL.gz,54675
GSM516776,Ovarian carcinoma_OC01_ARN0124 [HG-U133_Plus_2],GSM516776,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0124,histotype: Serous,tumor/metastasis: T,grade: 3,stade: IIIc,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516776/GSM516776.CEL.gz,54675
GSM516777,Ovarian carcinoma_OC01_ARN0125 [HG-U133_Plus_2],GSM516777,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0125,histotype: Serous,tumor/metastasis: T,grade: 3,stade: IIIc,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516777/GSM516777.CEL.gz,54675
GSM516778,Breast metastasis in the ovary_OC01_ARN0126 [HG-U133_Plus_2],GSM516778,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Breast metastasis in the ovary,Homo sapiens,tissue: Ovary,histology (disease state): Breast metastasis in the ovary,identifier: OC01_ARN0126,histotype: N/A,tumor/metastasis: M,grade: N/A,stade: N/A,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from breast metastasis in the ovary,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516778/GSM516778.CEL.gz,54675
GSM516779,Ovarian carcinoma_OC01_ARN0127 [HG-U133_Plus_2],GSM516779,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0127,histotype: Serous,tumor/metastasis: T,grade: 3,stade: IV,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516779/GSM516779.CEL.gz,54675
GSM516780,Ovarian carcinoma_OC01_ARN0128 [HG-U133_Plus_2],GSM516780,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0128,histotype: Serous,tumor/metastasis: T,grade: 3,stade: Ic,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516780/GSM516780.CEL.gz,54675
GSM516781,Ovarian carcinoma_OC01_ARN0129 [HG-U133_Plus_2],GSM516781,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0129,histotype: Endometrioid,tumor/metastasis: T,grade: 3,stade: IIIc,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516781/GSM516781.CEL.gz,54675
GSM516782,Ovarian carcinoma_OC01_ARN0130 [HG-U133_Plus_2],GSM516782,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0130,histotype: Serous,tumor/metastasis: T,grade: 3,stade: IIIc,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516782/GSM516782.CEL.gz,54675
GSM516783,Ovarian carcinoma_OC01_ARN0132 [HG-U133_Plus_2],GSM516783,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0132,histotype: Serous,tumor/metastasis: T,grade: 3,stade: IIIc,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516783/GSM516783.CEL.gz,54675
GSM516784,Ovarian carcinoma_OC01_ARN0133 [HG-U133_Plus_2],GSM516784,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0133,histotype: Serous,tumor/metastasis: T,grade: 3,stade: IIIc,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516784/GSM516784.CEL.gz,54675
GSM516785,Ovarian carcinoma_OC01_ARN0134 [HG-U133_Plus_2],GSM516785,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0134,histotype: Clear Cells,tumor/metastasis: T,grade: 2,stade: Ia,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516785/GSM516785.CEL.gz,54675
GSM516786,Ovarian carcinoma_OC01_ARN0135 [HG-U133_Plus_2],GSM516786,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0135,histotype: Serous,tumor/metastasis: T,grade: 3,stade: IIIc,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516786/GSM516786.CEL.gz,54675
GSM516787,Ovarian carcinoma_OC01_ARN0136 [HG-U133_Plus_2],GSM516787,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0136,histotype: Serous,tumor/metastasis: T,grade: 3,stade: IIIa,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516787/GSM516787.CEL.gz,54675
GSM516788,Ovarian carcinoma_OC01_ARN0137 [HG-U133_Plus_2],GSM516788,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0137,histotype: Mucinous,tumor/metastasis: T,grade: 2,stade: IIIc,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516788/GSM516788.CEL.gz,54675
GSM516789,Ovarian carcinoma_OC01_ARN0138 [HG-U133_Plus_2],GSM516789,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0138,histotype: Serous,tumor/metastasis: T,grade: 3,stade: IIc,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516789/GSM516789.CEL.gz,54675
GSM516790,Breast metastasis in the ovary_OC01_ARN0141 [HG-U133_Plus_2],GSM516790,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Breast metastasis in the ovary,Homo sapiens,tissue: Ovary,histology (disease state): Breast metastasis in the ovary,identifier: OC01_ARN0141,histotype: N/A,tumor/metastasis: M,grade: N/A,stade: N/A,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from breast metastasis in the ovary,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516790/GSM516790.CEL.gz,54675
GSM516791,Breast metastasis in the ovary_OC01_ARN0142 [HG-U133_Plus_2],GSM516791,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Breast metastasis in the ovary,Homo sapiens,tissue: Ovary,histology (disease state): Breast metastasis in the ovary,identifier: OC01_ARN0142,histotype: N/A,tumor/metastasis: M,grade: N/A,stade: N/A,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from breast metastasis in the ovary,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516791/GSM516791.CEL.gz,54675
GSM516792,Breast metastasis in the ovary_OC01_ARN0143 [HG-U133_Plus_2],GSM516792,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Breast metastasis in the ovary,Homo sapiens,tissue: Ovary,histology (disease state): Breast metastasis in the ovary,identifier: OC01_ARN0143,histotype: N/A,tumor/metastasis: M,grade: N/A,stade: N/A,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from breast metastasis in the ovary,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516792/GSM516792.CEL.gz,54675
GSM516793,Breast metastasis in the ovary_OC01_ARN0145 [HG-U133_Plus_2],GSM516793,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Breast metastasis in the ovary,Homo sapiens,tissue: Ovary,histology (disease state): Breast metastasis in the ovary,identifier: OC01_ARN0145,histotype: N/A,tumor/metastasis: M,grade: N/A,stade: N/A,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from breast metastasis in the ovary,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516793/GSM516793.CEL.gz,54675
GSM516794,Breast metastasis in the ovary_OC01_ARN0146 [HG-U133_Plus_2],GSM516794,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Breast metastasis in the ovary,Homo sapiens,tissue: Ovary,histology (disease state): Breast metastasis in the ovary,identifier: OC01_ARN0146,histotype: N/A,tumor/metastasis: M,grade: N/A,stade: N/A,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from breast metastasis in the ovary,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516794/GSM516794.CEL.gz,54675
GSM516795,Ovarian carcinoma_OC01_ARN0147 [HG-U133_Plus_2],GSM516795,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0147,histotype: Serous,tumor/metastasis: T,grade: 3,stade: IIIc,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516795/GSM516795.CEL.gz,54675
GSM516796,Ovarian carcinoma_OC01_ARN0148 [HG-U133_Plus_2],GSM516796,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0148,histotype: Carcinosarcome,tumor/metastasis: T,grade: 2,stade: IV,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516796/GSM516796.CEL.gz,54675
GSM516797,Ovarian carcinoma_OC01_ARN0149 [HG-U133_Plus_2],GSM516797,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0149,histotype: Serous,tumor/metastasis: T,grade: 3,stade: IIIc,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516797/GSM516797.CEL.gz,54675
GSM516798,Ovarian carcinoma_OC01_ARN0151 [HG-U133_Plus_2],GSM516798,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0151,histotype: Serous,tumor/metastasis: T,grade: 3,stade: IIIc,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516798/GSM516798.CEL.gz,54675
GSM516799,Ovarian carcinoma_OC01_ARN0152 [HG-U133_Plus_2],GSM516799,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0152,histotype: Serous,tumor/metastasis: T,grade: 3,stade: IV,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516799/GSM516799.CEL.gz,54675
GSM516800,Breast metastasis in the ovary_OC01_ARN0153 [HG-U133_Plus_2],GSM516800,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Breast metastasis in the ovary,Homo sapiens,tissue: Ovary,histology (disease state): Breast metastasis in the ovary,identifier: OC01_ARN0153,histotype: N/A,tumor/metastasis: M,grade: N/A,stade: N/A,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from breast metastasis in the ovary,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516800/GSM516800.CEL.gz,54675
GSM516801,Ovarian carcinoma_OC01_ARN0154 [HG-U133_Plus_2],GSM516801,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0154,histotype: Serous,tumor/metastasis: T,grade: 3,stade: IV,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516801/GSM516801.CEL.gz,54675
GSM516802,Ovarian carcinoma_OC01_ARN0155 [HG-U133_Plus_2],GSM516802,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0155,histotype: Serous,tumor/metastasis: T,grade: 2,stade: IIIc,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516802/GSM516802.CEL.gz,54675
GSM516803,Ovarian carcinoma_OC01_ARN0156 [HG-U133_Plus_2],GSM516803,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0156,histotype: Serous,tumor/metastasis: T,grade: 3,stade: IIIc,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516803/GSM516803.CEL.gz,54675
GSM516804,Ovarian carcinoma_OC01_ARN0157 [HG-U133_Plus_2],GSM516804,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0157,histotype: Serous,tumor/metastasis: T,grade: 3,stade: IV,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516804/GSM516804.CEL.gz,54675
GSM516805,Ovarian carcinoma_OC01_ARN0158 [HG-U133_Plus_2],GSM516805,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0158,histotype: Serous,tumor/metastasis: T,grade: 1,stade: Ia,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516805/GSM516805.CEL.gz,54675
GSM516806,Ovarian carcinoma_OC01_ARN0159 [HG-U133_Plus_2],GSM516806,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0159,histotype: Endometrioid,tumor/metastasis: T,grade: 2,stade: Ia,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516806/GSM516806.CEL.gz,54675
GSM516807,Plausible Breast metastasis in the ovary_OC01_ARN0160 [HG-U133_Plus_2],GSM516807,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Plausible Breast metastasis in the ovary,Homo sapiens,tissue: Ovary,histology (disease state): Plausible Breast metastasis in the ovary,identifier: OC01_ARN0160,histotype: N/A,tumor/metastasis: M,grade: N/A,stade: N/A,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from breast metastasis in the ovary,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516807/GSM516807.CEL.gz,54675
GSM516808,Ovarian carcinoma_OC01_ARN0161 [HG-U133_Plus_2],GSM516808,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0161,histotype: Serous,tumor/metastasis: T,grade: 3,stade: IV,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516808/GSM516808.CEL.gz,54675
GSM516809,Breast metastasis in the ovary_OC01_ARN0162 [HG-U133_Plus_2],GSM516809,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Breast metastasis in the ovary,Homo sapiens,tissue: Ovary,histology (disease state): Breast metastasis in the ovary,identifier: OC01_ARN0162,histotype: N/A,tumor/metastasis: M,grade: N/A,stade: N/A,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from breast metastasis in the ovary,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516809/GSM516809.CEL.gz,54675
GSM516810,Breast metastasis in the ovary_OC01_ARN0201 [HG-U133_Plus_2],GSM516810,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Breast metastasis in the ovary,Homo sapiens,tissue: Ovary,histology (disease state): Breast metastasis in the ovary,identifier: OC01_ARN0201,histotype: N/A,tumor/metastasis: M,grade: N/A,stade: N/A,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from breast metastasis in the ovary,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516810/GSM516810.CEL.gz,54675
GSM516811,Ovarian carcinoma_OC01_ARN0204 [HG-U133_Plus_2],GSM516811,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0204,histotype: Serous,tumor/metastasis: T,grade: 3,stade: IIa,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516811/GSM516811.CEL.gz,54675
GSM516812,Plausible Breast metastasis in the ovary_OC01_ARN0205 [HG-U133_Plus_2],GSM516812,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Plausible Breast metastasis in the ovary,Homo sapiens,tissue: Ovary,histology (disease state): Plausible Breast metastasis in the ovary,identifier: OC01_ARN0205,histotype: N/A,tumor/metastasis: M,grade: N/A,stade: N/A,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from breast metastasis in the ovary,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516812/GSM516812.CEL.gz,54675
GSM516813,Plausible Ovarian carcinoma_OC01_ARN0206 [HG-U133_Plus_2],GSM516813,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Plausible Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Plausible Ovarian carcinoma,identifier: OC01_ARN0206,histotype: Serous,tumor/metastasis: T,grade: 3,stade: Ic,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516813/GSM516813.CEL.gz,54675
GSM516814,Ovarian Carcinoma_OC01_ARN0207 [HG-U133_Plus_2],GSM516814,Public on Apr 14 2010,Mar 01 2010,Dec 15 2010,RNA,1,Ovarian Carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian Carcinoma,identifier: OC01_ARN0207,histotype: Serous,tumor/metastasis: T,grade: 3,stade: IIIc,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516814/GSM516814.CEL.gz,54675
GSM516815,Plausible Breast metastasis in the ovary_OC01_ARN0208 [HG-U133_Plus_2],GSM516815,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Plausible Breast metastasis in the ovary,Homo sapiens,tissue: Ovary,histology (disease state): Plausible Breast metastasis in the ovary,identifier: OC01_ARN0208,histotype: N/A,tumor/metastasis: M,grade: N/A,stade: N/A,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from breast metastasis in the ovary,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516815/GSM516815.CEL.gz,54675
GSM516816,Plausible Breast metastasis in the ovary_OC01_ARN0209 [HG-U133_Plus_2],GSM516816,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Plausible Breast metastasis in the ovary,Homo sapiens,tissue: Ovary,histology (disease state): Plausible Breast metastasis in the ovary,identifier: OC01_ARN0209,histotype: N/A,tumor/metastasis: M,grade: N/A,stade: N/A,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from breast metastasis in the ovary,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516816/GSM516816.CEL.gz,54675
GSM516817,Ovarian carcinoma_OC01_ARN0210 [HG-U133_Plus_2],GSM516817,Public on Apr 14 2010,Mar 01 2010,Apr 14 2010,RNA,1,Ovarian carcinoma,Homo sapiens,tissue: Ovary,histology (disease state): Ovarian carcinoma,identifier: OC01_ARN0210,histotype: Adenocarcinoma,tumor/metastasis: T,grade: 3,stade: IIIc,N/A,N/A,total RNA,Total RNA purification was conducted using miRNeasy kit,Biotin,"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix)_mRNA.",9606,"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2,0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.",GeneChips were scanned using the Affymetrix 7G Scanner GCS3000,Gene expression data from ovarian carcinoma,The data were processed/analyzed with gc-RMA (Partek Genomic Suite 6.09.1008).,GPL570,"Jean-Philippe,,MEYNIEL",jean-philippe.meyniel@curie.fr,33153194126,33153194130,Translational Research Dept,Institut Curie,"26, rue d'Ulm",PARIS,75248,France,ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM516nnn/GSM516817/GSM516817.CEL.gz,54675
